Liquid biopsy: Clues on prostate cancer drug resistance-Reference-Cited by-同舟云学术

Liquid biopsy: Clues on prostate cancer drug resistance

Published:2015-11-04 Issue:312 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Schweizer Michael T.¹,Antonarakis Emmanuel S.²

Affiliation:

1. Division of Oncology, Department of Medicine, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

2. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Abstract

Analysis of tumor-derived cell-free DNA in blood yields insights into drug resistance in patients with castration-resistant prostate cancer (Romanel et al ., this issue).

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference10 articles.

1. Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

2. Lineage dependency and lineage-survival oncogenes in human cancer

3. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

4. Integrative Clinical Genomics of Advanced Prostate Cancer

5. Molecular determinants of resistance to antiandrogen therapy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paper-Based Analytical Devices for Cancer Liquid Biopsy;Analytical Chemistry;2024-02-20

2. Next‐generation liquid biopsy instruments: Challenges and opportunities;ELECTROPHORESIS;2023-03-17

3. Leukocyte Depletion and Size-Based Enrichment of Circulating Tumor Cells Using a Pressure-Sensing Microfiltration Device;ACS Measurement Science Au;2022-12-08

4. Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse;Pharmaceuticals;2022-01-06

5. Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer;JCO Precision Oncology;2019-12